SELECTBIO Conferences Cell & Gene Therapy Asia 2019
Cell & Gene Therapy Asia 2019
-細胞治療及基因治療學會亞洲大會:2019年-
日期:2019年11月11-12日
地點:日本,兵庫縣神戶市,Sheraton Kobe Bay Hotel & Towers

ONLINE REGISTRATION WILL CLOSE ON NOVEMBER 7, 2019.

會議議長

Norio Nakatsuji

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

專題演講者

Kinichi Nakashima

Kinichi Nakashima
Professor, Department of Stem Cell Biology and Medicine, Kyushu University

Shoji Takeuchi

Shoji Takeuchi
Professor, Center For International Research on Integrative Biomedical Systems (CIBiS), Institute of Industrial Science, The University of Tokyo

Masafumi Onodera

Masafumi Onodera
Head, Department of Human Genetics, National Center for Child Health and Development

Takahiro Ochiya

Takahiro Ochiya
Professor, Tokyo Medical University

Noboru Yamaji

Noboru Yamaji
President, Chief Intelligence and Liaison Officer, Universal Cells, Inc., An Astellas Company

Keiya Ozawa

Keiya Ozawa
Professor Emeritus and Visiting Professor of the Division of Immuno-Gene & Cell Therapy, Jichi Medical University

Ross  Macdonald

Ross Macdonald
Chief Executive Officer and Managing Director, Cynata Therapeutics Ltd

Hiroshi Kawamoto

Hiroshi Kawamoto
Professor, Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University

Yuji Shiba

Yuji Shiba
Professor, Department of Regenerative Science and Medicine, Shinshu University

Chae-Ok Yun

Chae-Ok Yun
Professor, Department of Bioengineering, Hanyang University

概要

SelectBIO主辦的第2屆Cell & Gene Therapy Asia 2019、將於11月11日至12日、在兵庫縣神戶市舉行。

本會議齊聚來自學術界及產業界的細胞治療和基因治療領域研究人員,聚焦這個急速擴大領域的各種面向,討論細胞治療的幹細胞、iPS細胞和其研究發展、藥物研發細胞治療、包含CAR-T細胞的癌症免疫療法研究和臨床應用、因應基因治療的技術等。

本屆學會網羅細胞治療、基因治療、3D生物列印整體生態系統、細胞治療和基因治療、為了開發再生醫療臨床應用的3D培養、類器官、生物列印等技術平台等議題。

會期中,除了學術界研究發表之外,也透過企業展演、海報發表等展示最新研究成果;活動並安排了展示會,將能夠與來自日本、歐洲、美國、亞太地區等地與會代表建立關係。

神戶市擁有強健的生物醫療領域研究基盤,是舉辦Cell & Gene Therapy Asia 2019的理想都市。

京都大學教授中辻憲夫教授將擔任本屆學會主席,邀請年輕科學家踴躍參加海報發表及蒞臨學會。

募集海報發表

出席會議的同時,可以用海報發表研究成果。欲參加者,請在規定期限內繳交摘要,接受審查。

海報摘要提交截止日期: 2019年10月31日

議程主題

  • 3D生物列印和組織工程
  • 3D培養和類器官
  • 細胞治療的臨床試驗和商業化
  • 進入臨床試驗階段的基因治療
    • 臨床試驗
    • 監管情勢
    • 技術平台
  • 毒性測試、篩選、細胞治療之iPS細胞衍生細胞
  • 間質幹細胞 (MSC) :在細胞治療上的潛力
  • 再生醫療
  • 用於細胞治療的幹細胞

募集展商與贊助商

關於贊助與展出詳情歡迎隨時來信或來電詢問Global information Inc.

目前已確定的演講者

Toshiyoshi Fujiwara, Professor & Chairman, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Brian Ikeda, Sales Director, Allevi
Yasufumi Kaneda, Professor, Osaka University
Thai-Yen Ling, Associate Professor, National Taiwan University
Eugen Molodysky, Clinical Associate Professor, Sydney Medical School, University of Sydney
Ryuichi Morishita, Professor of Clinical Gene Therapy, Osaka University School of Medicine
Asuka Morizane, Assistant Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University
Shin-ichi Muramatsu , Professor of Neurology, Jichi Medical University (JMU)
Toshihiro Nakajima, Senior Technical Executive and General Manager of Manufacturing, GenomIdea, Inc.
Yasutomo Nasu, Professor, Okayama University
Kennedy Okeyo, Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
Jun Takahashi, Professor, Kyoto University
Ling-Mei Wang, President and COO, Steminent Biotherapeutics
William G Whitford, Strategic Solutions Leader Bioprocess, GE Healthcare Life Sciences
Haruka Yoshie, Application Specialist, CELLINK


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks
Choose your language
Chinese
Japanese
Korean
English



免費電子郵件通知服務